为了使您在Abcam官网的浏览体验更顺畅，请使用最新版本的浏览器比如 Google Chrome
Recombinant full length protein corresponding to Human Caspase-3.
Database link: P42574
Our Abpromise guarantee covers the use of ab2171 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/25 - 1/75.|
|IHC-Fr||1/25 - 1/75. ABC method.|
|IP||1/100 - 1/500.|
|WB||1/100 - 1/500.|
ab2171 staining Caspase-3 in formalin-fixed, paraffin-embedded human tonsil tissue by Immunohistochemistry.
Immunohistochemistry (Frozen sections) analysis of rabbit cornea tissue (on day 4, 10 and 15 after the injury) labelling Caspase-3 with ab2171. E − corneal epithelium. a – Caspase-3 staining is strong in the epithelium (particularly in superficial layers, arrows) of injured corneas on day 4 (a) as well as 10 (b) after the injury (arrows). c – On day 15 after the injury the expression of caspase-3 is present in the corneal epithelium as well as in the corneal stroma (arrows show to the cell apoptosis). The sections are counterstained with haematoxylin. Scale bar: 10 μM.
Immunohistochemistry (Frozen sections) analysis of rabbit cornea tissue (on day 4, 10 and 15 after the injury treated with MSCs) labelling Caspase-3 with ab2171. E − corneal epithelium. d – The expression of caspase-3 is reduced in the epithelium (arrows) of injured corneas treated with MSCs on nanofiber scaffolds from day 4 (d), day 10 (e) as well as day 15 (f) after the injury. Solely apoptosis (arrows) are seen. The sections are counterstained with haematoxylin.
Immunohistochemistry (Frozen sections) analysis of rabbit cornea tissue labelling Caspase-3 with ab2171. g - Caspase-3 expression is absent in a control cornea. h – The primary antibody is omitted from the incubation medium. The section is stained by counterstaining only (as a negative control for caspase-3). E − corneal epithelium.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"